Skip to main content
Premium Trial:

Request an Annual Quote

Follow the Money ... and Good Luck with Those Impartiality Rules

The amount of money that biomedical researchers receive from drug companies outstrips grants from the federal government, $55 billion versus $36 billion, respectively, reports the Los Angeles Times. With this funding, drug companies build close relationships with universities and their researchers who still appear to be impartial as they serve on committees that pen treatment standards and guidelines — recommendations from which those drug companies stand to benefit. "At present, the financial ties between the guidelines panels and industry are extensive," wrote Robert Steinbrook in last January's New England Journal of Medicine.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.